B-Cell Lymphomas Coverage from Every Angle

Manali Kamdar, MD, on Clinical Implications of New Findings on Lisocabtagene Maraleucel in Large B-Cell Lymphoma

Posted: Tuesday, February 1, 2022

Manali Kamdar, MD, of the University of Colorado Cancer Center, discusses the unmet need for better treatments of large B-cell lymphoma, the impetus for the TRANSFORM trial, and what this study showed about lisocabtagene maraleucel—a CAR T-cell therapy that may prove to be a possible new standard of care for second-line treatment of relapsed or refractory disease.

By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.